November 20, 2023 — FDA has a bone to pick with Otsuka, the company that sells Rexulti (brexpiprazole). The agency is taking issue with false advertising by the company for this drug used in schizophrenia and severe depression. To us, this problem of inflated efficacy claims is especially noteworthy because, for people with obesity who may need this drug, […]
January 7, 2023 — Who knew that FTC could be a source of support for scientific rigor? Well, late in December the agency issued new guidance – its first in 25 years – clarifying the standards it requires for businesses making health claims about their products. In this new guidance, FTC makes a clear call for RCTs (randomized controlled […]
March 26, 2021 — In case you haven’t noticed, many entrepreneurs are ready to sell us bunk to enhance our health. Sometimes it comes in the form of alternative medicine, as Tim Caulfield so aptly describes. Very often, the better-for-you bunk comes in the form of ultra-processed foods with claims like GMO-free and all-natural – to help people rationalize […]
